Modifications in an emergency: the role of N1-methylpseudouridine in COVID-19 vaccines

KD Nance, JL Meier - ACS central science, 2021 - ACS Publications
The novel coronavirus SARS-CoV-2, the cause of the COVID-19 pandemic, has inspired
one of the most efficient vaccine development campaigns in human history. A key aspect of …

The mRNA vaccine revolution: COVID-19 has launched the future of vaccinology

Z Ye, J Harmon, W Ni, Y Li, D Wich, Q Xu - ACS nano, 2023 - ACS Publications
During the COVID-19 pandemic, mRNA (mRNA) vaccines emerged as leading vaccine
candidates in a record time. Nonreplicating mRNA (NRM) and self-amplifying mRNA (SAM) …

[HTML][HTML] Detailed dissection and critical evaluation of the Pfizer/BioNTech and Moderna mRNA vaccines

X Xia - Vaccines, 2021 - mdpi.com
The design of Pfizer/BioNTech and Moderna mRNA vaccines involves many different types
of optimizations. Proper optimization of vaccine mRNA can reduce dosage required for each …

[HTML][HTML] Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2

JT Granados-Riveron, G Aquino-Jarquin - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Currently, there are over 230 different COVID-19 vaccines under development around the
world. At least three decades of scientific development in RNA biology, immunology …

Vaccine mRNA can be detected in blood at 15 days post-vaccination

TE Fertig, L Chitoiu, DS Marta, VS Ionescu… - Biomedicines, 2022 - mdpi.com
COVID-19 mRNA vaccines effectively reduce incidence of severe disease, hospitalisation
and death. The biodistribution and pharmacokinetics of the mRNA-containing lipid …

N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products

KQ Kim, BD Burgute, SC Tzeng, C Jing, C Jungers… - Cell Reports, 2022 - cell.com
Synthetic mRNA technology is a promising avenue for treating and preventing disease. Key
to the technology is the incorporation of modified nucleotides such as N1 …

Computational design of mRNA vaccines

YA Kim, K Mousavi, A Yazdi, M Zwierzyna, M Cardinali… - Vaccine, 2024 - Elsevier
Abstract mRNA technology has emerged as a successful vaccine platform that offered a swift
response to the COVID-19 pandemic. Accumulating evidence shows that vaccine efficacy …

Neutralizing activity and SARS-CoV-2 vaccine mRNA persistence in serum and breastmilk after BNT162b2 vaccination in lactating women

KT Yeo, WN Chia, CW Tan, C Ong, JG Yeo… - Frontiers in …, 2022 - frontiersin.org
Background There is limited information on the functional neutralizing capabilities of
breastmilk SARS-CoV-2-specific antibodies and the potential adulteration of breastmilk with …

Cardiac side effects of RNA‐based SARS‐CoV‐2 vaccines: hidden cardiotoxic effects of mRNA‐1273 and BNT162b2 on ventricular myocyte function and structure

R Schreckenberg, N Woitasky, N Itani… - British Journal of …, 2024 - Wiley Online Library
Abstract Background and Purpose To protect against SARS‐CoV‐2 infection, the first mRNA‐
based vaccines, Spikevax (mRNA‐1273, Moderna) and Comirnaty (BNT162b2 …

N1-methyl-pseudouridine is incorporated with higher fidelity than pseudouridine in synthetic RNAs

TH Chen, V Potapov, N Dai, JL Ong, B Roy - Scientific Reports, 2022 - nature.com
In vitro transcribed synthetic messenger RNAs (mRNAs) represent a novel therapeutic
modality. To overcome the inherent immunogenicity, as well as to increase the therapeutic …